aminolevulinic acid has been researched along with Anxiety in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, AB | 1 |
| Daneshmand, S | 1 |
| Patel, S | 1 |
| Pohar, K | 1 |
| Trabulsi, E | 1 |
| Woods, M | 1 |
| Downs, T | 1 |
| Huang, W | 1 |
| Taylor, J | 1 |
| Jones, J | 1 |
| O'Donnell, M | 1 |
| Bivalacqua, T | 1 |
| DeCastro, J | 1 |
| Steinberg, G | 1 |
| Kamat, A | 1 |
| Resnick, M | 1 |
| Konety, B | 1 |
| Schoenberg, M | 1 |
| Jones, JS | 1 |
| Lotan, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients Wit[NCT02560584] | Phase 3 | 304 participants (Actual) | Interventional | 2015-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02560584)
Timeframe: At time of cystoscopy procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Surveillance Examination | 6 |
| Surveillance + OR Examination | 3 |
In the subsection of patients with histologically confirmed malignancy, the proportion of patients detected only by the use of blue light cystoscopy with Cysview is measured. (NCT02560584)
Timeframe: At time of cystoscopy procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Cysview Arm | 13 |
In the subsection of patients with histologically confirmed CIS, the proportion of patients detected only by blue light cystoscopy with Cysview is measured. (NCT02560584)
Timeframe: At time of cystoscopy procedure
| Intervention | Participants (Count of Participants) |
|---|---|
| Cysview Arm | 9 |
1 trial available for aminolevulinic acid and Anxiety
| Article | Year |
|---|---|
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study.
Topics: Aged; Aminolevulinic Acid; Anxiety; Color; Cystoscopy; False Positive Reactions; Female; Fluorescent | 2019 |